Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-15

FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Trifluent Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for dicyclomine hydrochloride submitted by Trifluent Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dicyclomine hydrochloride (Dicyclomine hydrochloride)

Snippet

SUPPL AP for DICYCLOMINE HYDROCHLORIDE (DICYCLOMINE HYDROCHLORIDE)